V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013582 | 270009176 | null | 102 | Curative (C) | 2013-01-21 | 2013-01-24 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270015218 | OEPA |
| 270013583 | 270009180 | 1.77 | 78 | Curative (C) | 2017-12-16 | 2017-12-16 | HD EuroNet-PHL-C1 OEPA | N | N | 270015219 | OEPA |
| 270013584 | 270009180 | 1.56 | null | Not known (9) | 2015-03-10 | 2015-03-17 | Rituximab | null | null | 270015219 | RITUXIMAB |
| 270013585 | 270018322 | 1.69 | 92 | Curative (C) | 2016-06-26 | 2016-07-21 | CISPLATIN + RT | N | N | 270015224 | CISPLATIN + RT |
| 270013586 | 270014294 | 1.83 | 61.7 | Palliative (P) | 2016-12-31 | 2017-01-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015224 | CETUXIMAB + IRINOTECAN + MDG |
| 270013587 | 270014295 | 0 | 45.8 | Curative (C) | 2016-04-04 | 2016-04-04 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | 270015226 | CETUXIMAB + IRINOTECAN + MDG |
| 270013588 | 270009184 | 1.7 | 81.5 | Curative (C) | 2014-08-11 | 2016-06-22 | Rituximab (Maintenance) | N | N | 270015226 | RITUXIMAB |
| 270013589 | 270009185 | 1.92 | 54.2 | Neo-adjuvant (N) | 2013-05-04 | 2013-05-04 | HD EuroNet-PHL-C1 OEPA | 02 | null | 270015227 | OEPA |
| 270013590 | 270009186 | 1.61 | 61.1 | Neo-adjuvant (N) | 2015-07-15 | 2016-04-28 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015236 | CETUXIMAB + IRINOTECAN + MDG |
| 270013591 | 270009189 | 1.67 | 69 | Curative (C) | 2017-08-19 | 2017-08-19 | ESHAP | 2 | N | 270015239 | ESHAP |
| 270013592 | 270009191 | 1.77 | 53.2 | Curative (C) | 2014-04-05 | 2014-04-17 | CISPLATIN + RT | 02 | N | 270015246 | CISPLATIN + RT |
| 270013593 | 270019169 | 1.87 | 57.6 | Curative (C) | 2016-03-31 | 2016-07-31 | Rituximab | N | N | 270015246 | RITUXIMAB |
| 270013594 | 270009195 | null | 97 | Disease modification (D) | 2014-05-31 | 2014-08-02 | BEAM | 02 | null | 270015247 | BEAM |
| 270013595 | 270009195 | 1.74 | 92.9 | Curative (C) | 2017-10-21 | 2017-10-29 | ESHAP | 02 | 2 | 270015247 | ESHAP |
| 270013596 | 270009197 | 1.73 | 59 | Curative (C) | null | 2014-04-09 | Cisplatin + Radiotherapy | N | N | 270015252 | CISPLATIN + RT |
| 270013597 | 270014303 | 1.72 | 120 | Curative (C) | 2017-02-07 | 2017-02-17 | ESHAP | N | N | 270015254 | ESHAP |
| 270013598 | 270009201 | 1.63 | 69.8 | Disease modification (D) | 2017-07-23 | 2017-08-06 | LEAM | N | N | 270015254 | LEAM |
| 270013599 | 270009201 | 1.72 | 38.1 | Curative (C) | 2017-05-27 | 2017-05-29 | BEAM | N | Y | 270015254 | BEAM |
| 270013600 | 270009202 | 1.78 | 91.8 | Curative (C) | null | 2019-01-17 | BEAM | 02 | N | 270015263 | BEAM |
| 270013601 | 270014305 | 1.69 | 55.85 | Disease modification (D) | 2017-01-20 | 2017-02-01 | BEAM | 2 | N | 270015268 | BEAM |
| 270013602 | 270009204 | 1.41 | 79.8 | null | 2016-11-20 | 2016-11-20 | Rituximab | 02 | N | 270015269 | RITUXIMAB |
| 270013603 | 270009206 | 1.77 | 68 | Curative (C) | 2013-02-26 | 2013-04-23 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270015271 | CISPLATIN + RT |
| 270013604 | 270009207 | 1.82 | 87 | Curative (C) | 2016-03-03 | 2016-04-12 | Cisplatin + Radiotherapy | 02 | null | 270015274 | CISPLATIN + RT |
| 270013605 | 270009208 | null | 84 | null | 2017-07-28 | 2017-07-28 | LEAM | N | N | 270015275 | LEAM |
| 270013606 | 270014307 | 1.45 | 112 | null | 2016-08-02 | 2016-08-09 | OEPA | 2 | N | 270015276 | OEPA |
| 270013607 | 270018327 | 1.75 | 52.95 | Curative (C) | 2016-07-23 | 2016-08-16 | Cisplatin + Radiotherapy | N | N | 270015276 | CISPLATIN + RT |
| 270013608 | 270018327 | 1.71 | null | Curative (C) | 2016-08-25 | 2016-08-28 | BEAM | N | N | 270015276 | BEAM |
| 270013609 | 270009212 | 1.66 | null | Curative (C) | 2014-09-19 | 2014-09-23 | ESHAP | N | N | 270015286 | ESHAP |
| 270013610 | 270009215 | 1.84 | 96.5 | Curative (C) | 2014-01-27 | 2015-09-20 | ESHAP | N | N | 270015286 | ESHAP |
| 270013611 | 270019653 | 1.68 | 95.4 | Curative (C) | 2017-01-20 | 2017-01-29 | ESHAP | N | null | 270015292 | ESHAP |
| 270013612 | 270019653 | null | 63.1 | Curative (C) | 2014-05-06 | 2014-06-20 | OEPA | N | N | 270015292 | OEPA |
| 270013613 | 270009220 | 1.79 | 59.1 | Curative (C) | null | 2016-12-22 | Rituximab (Maintenance) | 02 | null | 270015300 | RITUXIMAB |
| 270013615 | 270009225 | 1.71 | 83.6 | Curative (C) | 2015-03-20 | 2015-04-03 | BEAM | N | N | 270015303 | BEAM |
| 270013616 | 270014311 | 1.83 | 89.5 | Palliative (P) | 2018-01-07 | 2018-05-21 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015303 | CETUXIMAB + IRINOTECAN + MDG |
| 270013617 | 270009227 | 1.64 | 78.3 | Curative (C) | 2014-09-19 | 2014-12-16 | CISPLATIN + RT | 02 | N | 270015306 | CISPLATIN + RT |
| 270013618 | 270014312 | 1.77 | 75.6 | Palliative (P) | 2014-04-27 | 2014-05-11 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015309 | CETUXIMAB + IRINOTECAN + MDG |
| 270013619 | 270019924 | 1.6 | 67.7 | Curative (C) | null | 2016-04-07 | BEAM | N | null | 270015310 | BEAM |
| 270013620 | 270009230 | null | 67.5 | Curative (C) | 2015-03-31 | 2015-11-11 | ESHAP | 02 | N | 270015310 | ESHAP |
| 270013621 | 270009230 | 1.56 | null | Neo-adjuvant (N) | 2016-08-01 | 2016-08-16 | OEPA | N | N | 270015310 | OEPA |
| 270013622 | 270009231 | 1.73 | 37.4 | Neo-adjuvant (N) | 2016-09-25 | 2016-10-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 270015319 | CETUXIMAB + IRINOTECAN + MDG |
| 270013623 | 270009231 | 1.98 | 58.9 | Curative (C) | 2016-12-24 | 2016-12-26 | Rituximab | 2 | N | 270015319 | RITUXIMAB |
| 270013624 | 270009231 | 1.65 | 52.5 | Palliative (P) | 2015-01-31 | 2015-02-12 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015319 | CETUXIMAB + IRINOTECAN + MDG |
| 270013625 | 270009232 | 2 | 50.6 | Curative (C) | 2017-06-01 | 2017-06-01 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 270015322 | RITUXIMAB |
| 270013626 | 270009232 | 1.7 | 92 | Palliative (P) | 2014-04-03 | 2014-04-03 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 270015322 | RITUXIMAB |
| 270013627 | 270009232 | 1.66 | 52.4 | Neo-adjuvant (N) | 2013-12-29 | 2013-12-30 | Cetuximab + FOLFIRI cycle 2 onwards | Y | N | 270015322 | CETUXIMAB + IRINOTECAN + MDG |
| 270013628 | 270009234 | 1.68 | 73 | Curative (C) | null | 2017-05-24 | OEPA | 2 | N | 270015329 | OEPA |
| 270013629 | 270014316 | 1.86 | 92.9 | Curative (C) | 2018-03-09 | 2018-03-22 | HD EuroNet-PHL-C1 OEPA | N | N | 270015329 | OEPA |
| 270013630 | 270009236 | 1.24 | null | Curative (C) | 2017-04-07 | 2018-01-08 | BEAM | N | N | 270015332 | BEAM |
| 270013631 | 270009236 | 1.66 | null | Curative (C) | 2014-04-20 | 2014-04-21 | ESHAP | 2 | N | 270015332 | ESHAP |
| 270013632 | 270019178 | 1.85 | 55.8 | Palliative (P) | 2013-10-18 | 2013-10-28 | Rituximab | 01 | N | 270015333 | RITUXIMAB |